Century Therapeutics Inc

IPSCNASDAQ · USD
1.86USD0.00 (0.00%)
1510

Century Therapeutics Inc (IPSC) Implied Volatility Current

IPSC implied volatility is 311%. IV Rank is 65%, placing current premiums in the middle of their 52-week range.

Read more

Tracking IPSC implied volatility helps you identify when options premiums on Century Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Century Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when IPSC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Century Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IPSC, tracking metrics like IPSC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IPSC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma.

Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IPSC implied volatility sits today versus where it has been. Our scanner ranks Century Therapeutics Inc implied volatility against its historical range, surfaces extremes in IPSC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Century Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
65.08%IV Rank
Moderate

IV is slightly elevated - premiums are richer, leaning toward sellers.

Implied Volatility (30d)311.22%

IV Rank65.08%

Historical Volatility (30d)57.53%

IV - HV+253.69%

As of September 16, 2026

Trade options with IV on your side

Track IPSC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial